Pathobiology of pulmonary arterial hypertension and right ventricular failure - Wikidata - awgldk - TriplyDB

Pathobiology of pulmonary arterial hypertension and right ventricular failure

Pathobiology of pulmonary arterial hypertension and right ventricular failure

http://www.wikidata.org/entity/Q26821779

about

The molecular targets of approved treatments for pulmonary arterial hypertension Right ventricular failure and pathobiology in patients with congenital heart disease - implications for long-term follow-up Emerging roles for histone deacetylases in pulmonary hypertension and right ventricular remodeling (2013 Grover Conference series)Increased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertension IL-32 promotes angiogenesis.Effects of 17β-estradiol and 2-methoxyestradiol on the oxidative stress-hypoxia inducible factor-1 pathway in hypoxic pulmonary hypertensive rats N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats Identifying "super responders" in pulmonary arterial hypertension.Pentraxin-3 and the right ventricle: the Multi-Ethnic Study of Atherosclerosis-Right Ventricle Study.Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.Transient Intervals of Hyper-Gravity Enhance Endothelial Barrier Integrity: Impact of Mechanical and Gravitational Forces Measured Electrically The crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension.Bax deficiency extends the survival of Ku70 knockout mice that develop lung and heart diseases.O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension.The need to recognize the pulmonary circulation and the right ventricle as an integrated functional unit: facts and hypotheses (2013 Grover Conference series).Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFβ-induced pulmonary fibrosis.Nanoliposomal Nitroglycerin Exerts Potent Anti-Inflammatory Effects.Pulmonary vascular remodeling and right heart failure in pulmonary hypertension: future role of positron emission tomography in decoding the enigma.Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension.Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study.Bax-induced apoptosis shortens the life span of DNA repair defect Ku70-knockout mice by inducing emphysema Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension.Upregulated miR-17 Regulates Hypoxia-Mediated Human Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis by Targeting Mitofusin 2.BK channels in rat and human pulmonary smooth muscle cells are BKα-β1 functional complexes lacking the oxygen-sensitive stress axis regulated exon insert.Lack of ABCG2 Leads to Biventricular Dysfunction and Remodeling in Response to Hypoxia Progressive right ventricular functional and structural changes in a mouse model of pulmonary arterial hypertension.Evidence for the involvement of type I interferon in pulmonary arterial hypertension.Pulmonary hypertension in Kawasaki disease.Reactive oxygen species as therapeutic targets in pulmonary hypertension.The role of hypoxia in pulmonary vascular diseases: a perspective.Pulmonary arterial hypertension: challenges in translational research and a vision for change.Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases.State of the art: advanced imaging of the right ventricle and pulmonary circulation in humans (2013 Grover Conference series)Treatment for pulmonary arterial hypertension-associated right ventricular dysfunction.Endothelial nanomedicine for the treatment of pulmonary disease.Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy.Evolving targeted therapies for right ventricular failure.

P2860

Q26798308-D46D88C4-D96B-4060-8B98-2B61370C849B Q27026319-2177B9E8-98BE-477D-B11F-93951DBECD81 Q28082797-7E6E65F0-E8BF-47D8-B1C1-511F809D2596 Q28544637-12662FA0-4347-46EF-860F-1CCBB21251F5 Q33555523-2D858FD6-4C2C-4B65-AA55-96611BB6C5BE Q33723858-7EDE5398-D081-440F-9A3E-62E52C21D076 Q33786092-F8A5FC68-111F-462B-993F-66BD0AEB8C3A Q33788452-BF408EEF-7C3F-43A7-9BA2-9DDE54D0A22D Q33805985-2C09A5A5-5BBD-421B-8AAE-FDACF65B9287 Q34270071-44D4D1B8-4E48-4CAB-AF9D-085AAB583F05 Q34504125-C5F96405-CE17-4F54-95C5-E876B760F9DA Q34924892-67082BF1-9468-44B7-9CC7-99F7DE994366 Q35274410-0A772159-1F55-44A2-BCE9-EF9AF2892D98 Q35328516-0B566F53-0139-4841-8BF8-4EE2482E8A58 Q35517479-39D7A176-EF5E-4979-B934-C5D9572E8A88 Q35517559-6C934D38-6F47-47E8-B54B-CDEC8AF30477 Q35825326-F324595D-CD1B-48C2-9386-63157C08D4ED Q35978150-4056D3D4-648C-48EB-A75C-484F808C0E0E Q36301173-F8F99F11-8442-46BC-A13E-00DED7E1B58A Q36468672-E1E87CF3-A8E8-493E-8CD2-18D75F2A7723 Q36516814-008BD1FF-4156-4386-8503-9B2E60E08D2A Q36923968-DAC6A6D9-013E-4058-8A81-0054F4FC9E4A Q37094621-673A87CC-486E-49AE-921B-E268A6285BB7 Q37106941-CE71462D-A7C9-4FD8-BD0C-7B5D69A983F3 Q37216215-5254AF82-C19D-4696-981D-AC437C99275D Q37268141-77E9AD48-C08E-4BEA-A2D2-7EBB52ED853A Q37555406-A8C0BC49-BE07-4DC9-9C25-26DEE4CE381C Q37653867-09A8FB5E-4C1E-4F7A-9E21-1F1BE35FA441 Q37675518-DC7C38E7-92C3-4364-8432-75AAE0B323F2 Q37735087-DBC99331-FFF0-4AF2-AE3D-0B05A1821396 Q38044281-40F65DF5-84A5-4109-B305-622E3448ED77 Q38074770-D3DD4F4F-4BDB-4572-A375-37D33B63F016 Q38078782-05A600F1-6219-4D73-87E7-5EA40E90875F Q38155079-AA4C2A7B-333F-4F34-898E-E99C31DC84BB Q38165146-574D4171-C7C7-4D85-A2A9-ABB34ECC4A64 Q38227556-01DE9ED1-5718-4C73-AD8C-5EDDCD358071 Q38235602-C5539993-F0BD-444E-9FB9-73ED7D9E55ED Q38267984-35CCF4E1-4C0D-491B-9B37-256B03E44D34 Q38524717-6C265930-6B7D-46D0-BA30-AEFEE46C9C55 Q38559308-7CDB04DD-9AE1-43D3-A25E-2F95D3D2B49F

P2860

Pathobiology of pulmonary arterial hypertension and right ventricular failure

http://www.wikidata.org/entity/Q26821779

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Pathobiology of pulmonary arterial hypertension and right ventricular failure

@ast

Pathobiology of pulmonary arterial hypertension and right ventricular failure

@en

Pathobiology of pulmonary arterial hypertension and right ventricular failure

@nl

type

label

Pathobiology of pulmonary arterial hypertension and right ventricular failure

@ast

Pathobiology of pulmonary arterial hypertension and right ventricular failure

@en

Pathobiology of pulmonary arterial hypertension and right ventricular failure

@nl

prefLabel

Pathobiology of pulmonary arterial hypertension and right ventricular failure

@ast

Pathobiology of pulmonary arterial hypertension and right ventricular failure

@en

Pathobiology of pulmonary arterial hypertension and right ventricular failure

@nl

P1433

Q26821779-7E820CA4-02DC-4C9C-A186-B22B59364907

P1476

Q26821779-1122BE84-CF77-4578-A432-38B2B2A42691

P2093

Q26821779-07F4C39A-4EB7-4EF6-B5D9-97AA4E491FBB

Q26821779-707D9F51-CD23-4364-83C2-2E82E92449D5

Q26821779-9A655D79-320B-4BE9-8E5E-98E9A44C6008

Q26821779-CA9D5361-F3EA-42A6-9782-9D84CD96F2FE

Q26821779-F8C007C4-CA86-4734-A1C4-F1593BAAB4AB

P2860

Q26821779-014B3F24-8CB9-4C6B-B168-797892306E41

Q26821779-01CBA089-0DA7-4350-8FB4-99704B43504A

Q26821779-0316DDFD-FABE-4806-B2B3-35088B908E4F

Q26821779-0DAB5C6F-1651-4219-8E31-855097CE6446

Q26821779-0F82A4E8-7264-42D3-A3AB-90F81E07206C

Q26821779-189656EF-66F0-47D1-85C4-1A03B78DCB7C

Q26821779-1D3B461E-A1DF-4875-9B9E-36EC4EC72792

Q26821779-1D6F26A1-76C7-4597-BCE5-5DEFC80EF49E

Q26821779-1DAABAE8-AC3F-4FDA-A0CE-7A62CDE2A4C2

Q26821779-1EC779FA-B181-43C1-996E-DD9EDF4EBE75

P304

Q26821779-207BBB09-A218-45DC-B7B8-3067C9514B4D

P31

Q26821779-46CB2D88-C7D1-4B80-BF5B-AAC5E112B9C3

P3181

Q26821779-3C11D11B-E2EB-4348-B4F8-BFDA26A8ABEF

P356

Q26821779-1844FD26-6A5E-46B1-9FE1-94BF4E9D6A86

P407

Q26821779-F967379E-2751-4AC4-9C8E-D733E102C674

P433

Q26821779-69474EDF-A699-4074-9E67-CB8F91598967

P478

Q26821779-31B17799-404E-4210-A59A-6998932E6605

P577

Q26821779-03903AB8-0C5F-4A65-94C5-6A1FB91045F5

P5875

Q26821779-3CB64A26-AF9E-432E-905C-BA8ECF38BCF0

P698

Q26821779-A8F44900-C0DB-447C-BDFE-7250ACEAE4AA

P921

Q26821779-667F3AC5-439C-4959-B0D8-276979A7B2FC

P932

Q26821779-E503C647-571C-4A60-A4CF-0C6307763F66

P3181

P356

09031936.00046612

P1433

European Respiratory Journal

P1476

Pathobiology of pulmonary arterial hypertension and right ventricular failure

@en

P2093

Antonio Abbate

http://www.w3.org/2001/XMLSchema#string

Harm J. Bogaard

http://www.w3.org/2001/XMLSchema#string

Jose Gomez-Arroyo

http://www.w3.org/2001/XMLSchema#string

Mark R. Nicolls

http://www.w3.org/2001/XMLSchema#string

Norbert F. Voelkel

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway

CD4+ T-lymphocytopenia--a frequent finding in anti-SSA antibody seropositive patients with primary Sjögren's syndrome

Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.

Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression

Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.

P304

1555-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3476980

http://www.w3.org/2001/XMLSchema#string

P356

10.1183/09031936.00046612

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228087754

http://www.w3.org/2001/XMLSchema#string

P698

22743666

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

4019748

http://www.w3.org/2001/XMLSchema#string